Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

What Are Whales Doing With Eli Lilly

A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly.

Looking at options history for Eli Lilly (NYSE:LLY) we detected 10 strange trades.

If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 50% with bearish.

From the overall spotted trades, 3 are puts, for a total amount of $368,432 and 7, calls, for a total amount of $369,711.

What's The Price Target?

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $270.0 to $350.0 for Eli Lilly over the last 3 months.

Volume & Open Interest Development

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

This data can help you track the liquidity and interest for Eli Lilly's options for a given strike price.

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Eli Lilly's whale activity within a strike price range from $270.0 to $350.0 in the last 30 days.

Eli Lilly Option Volume And Open Interest Over Last 30 Days

Biggest Options Spotted:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Strike Price Total Trade Price Open Interest Volume
LLY PUT TRADE BULLISH 11/18/22 $270.00 $186.0K 1.2K 435
LLY PUT TRADE BULLISH 10/21/22 $280.00 $149.2K 1.5K 535
LLY CALL SWEEP BEARISH 01/19/24 $350.00 $98.1K 210 28
LLY CALL SWEEP BEARISH 01/20/23 $300.00 $82.2K 1.3K 37
LLY CALL SWEEP BEARISH 01/19/24 $350.00 $44.7K 210 383

Where Is Eli Lilly Standing Right Now?

  • With a volume of 809,797, the price of LLY is down -0.32% at $308.63.
  • RSI indicators hint that the underlying stock is currently neutral between overbought and oversold.
  • Next earnings are expected to be released in 40 days.

What The Experts Say On Eli Lilly:

  • BMO Capital has decided to maintain their Outperform rating on Eli Lilly, which currently sits at a price target of $396.
  • Morgan Stanley has decided to maintain their Overweight rating on Eli Lilly, which currently sits at a price target of $412.

Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.

If you want to stay updated on the latest options trades for Eli Lilly, Benzinga Pro gives you real-time options trades alerts.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.